Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy injections are not usually painful. Most people feel little more than a mild sting or brief pressure at the injection site, and many notice nothing at all after the first few weeks. That said, discomfort is real for some people at certain times — at the start of treatment, after a dose step, or if the technique needs a small adjustment. These are prescription-only medicines that require a clinical assessment before a prescriber decides whether they are suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is: rarely, and usually only a little. The Wegovy pen uses a very fine needle, and the injection is subcutaneous (under the skin rather than into muscle) which is a gentler route than many people picture. A common misconception is that self-injecting a weekly weight-loss medicine must feel like a hospital jab. It doesn't. The needle is short and thin, the pressure lasts a second, and most people are surprised by how unremarkable it feels.
Suitable sites are the abdomen, the outer thigh, or the upper arm. Rotating between these each week means no single patch of skin gets overworked. Pinching the skin gently before pressing the pen in, and making sure the pen has been out of the fridge long enough to lose its chill, both reduce the chance of a sting. Cold medicine through a cold needle into unprepared skin is usually where the discomfort comes from. There's a more detailed look at the shot itself if you want to go further into technique.
The Wegovy pen is pre-filled and auto-injecting, you press it against the skin and it does the rest. You don't manually push a plunger, which removes one more source of hesitation. For the vast majority of people, the injecting part stops being a thing they think about after the first two or three doses.
Some localised tenderness, redness or mild swelling at the injection site in the hours after a dose is listed as a common side effect in the trial data published in the STEP 1 study in the New England Journal of Medicine. For most people it settles within a day. Itching around the site is occasionally reported too, especially in the first few weeks of treatment.
If the same spot is used repeatedly without rotation, low-grade inflammation can build up, the skin can feel firm or bumpy under the surface over time. That's a technique issue rather than a medicine issue, and it's entirely avoidable by moving the site with each dose.
Bruising is possible, particularly for people on blood-thinning medicines, but it's not the norm. The NHS semaglutide medicines page lists the full side-effect profile in plain language and is worth reading before you start treatment. A prescriber will always go through contraindications and any relevant medicines with you before a decision is made.
This is a question our prescribers hear regularly, and it's worth separating the different types of discomfort people attribute to treatment. Muscle aches, joint soreness and skin sensitivity are all reported by some people on semaglutide, though they are not among the most commonly listed effects. Rapid weight loss can itself shift the load on joints and change how muscles work, so some of what people notice may reflect the body adjusting rather than a direct pharmacological effect.
If you're noticing muscle pain on Wegovy, that's worth looking at specifically, as is joint discomfort. Skin sensitivity is less frequently discussed but does come up, there's a dedicated page on that if it's something you've noticed.
Abdominal discomfort is the more common reported pain on treatment, usually related to the gastrointestinal effects of semaglutide: nausea, slowed gastric emptying, and the digestive system adjusting. This tends to be most noticeable in the first few weeks at a new dose and settles for most people as the body adapts. Severe or persistent stomach pain radiating to the back is different, that requires prompt medical attention.
For most people, the opposite is true. The early weeks of any injection routine come with a learning curve: figuring out which site feels most comfortable, building confidence with the pen, getting the prep right. Once that becomes habit, the injection is simply part of a weekly routine, like taking a regular medicine, only once a week rather than every day.
If a particular dose felt more uncomfortable than usual, that's worth noting but not necessarily worrying about. An injection that hurt more than normal usually has a practical explanation: a slightly different angle, a colder pen, a spot that was already a little tender. It doesn't mean the medicine has changed or that something has gone wrong.
If you're weighing up options or thinking about whether injections are right for you, the weight-loss treatment overview covers the landscape, including injectable and oral choices currently available. And if you'd like to explore whether Wegovy is clinically suitable for you, including any concerns about managing injections, our prescribers are the right people to speak with.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.